Diaceutics Plc Stock Today
| DIUXF Stock | USD 1.37 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressLow
|
Diaceutics PLC is trading at 1.37 as of the 8th of January 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.37. Diaceutics PLC has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 9th of November 2025 and ending today, the 8th of January 2026. Click here to learn more.
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom. Diaceutics Plc is traded on OTC Exchange in the United States.. The company has 84.47 M outstanding shares. More on Diaceutics PLC
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Diaceutics Pink Sheet Highlights
| Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
Diaceutics PLC [DIUXF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Micro-Cap' category with a current market capitalization of 94.61 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Diaceutics PLC's market, we take the total number of its shares issued and multiply it by Diaceutics PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Diaceutics PLC classifies itself under Healthcare sector and is part of Diagnostics & Research industry. The entity has 84.47 M outstanding shares.
Diaceutics PLC has accumulated about 19.68 M in cash with 570 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check Diaceutics PLC Probability Of Bankruptcy
Ownership AllocationDiaceutics PLC holds a total of 84.47 Million outstanding shares. Diaceutics PLC retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Diaceutics Ownership Details
Diaceutics Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Diaceutics PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Diaceutics PLC Corporate Management
| Scott Morrison | Head Science | Profile | |
| Gillian Shaw | G Counsel | Profile | |
| Norma Thompson | Global HR | Profile | |
| Jordan Clark | Chief Officer | Profile | |
| Nicholas Roberts | CFO Director | Profile | |
| Jillian Beggs | VP Marketing | Profile | |
| Julie Browne | Chief Officer | Profile |
Other Information on Investing in Diaceutics Pink Sheet
Diaceutics PLC financial ratios help investors to determine whether Diaceutics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diaceutics with respect to the benefits of owning Diaceutics PLC security.